Literature DB >> 3037168

Risks of angiotensin converting enzyme inhibition in renal artery stenosis.

G J Wenting, F H Derkx, L H Tan-Tjiong, A J van Seyen, A J Man in't Veld, M A Schalekamp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3037168

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN： 0098-6577            Impact factor:   10.545


× No keyword cloud information.
  5 in total

1.  Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association.

Authors: 
Journal:  Heart       Date:  1998-12       Impact factor: 5.994

Review 2.  Quantification of renal haemodynamics with radionuclides.

Authors:  A M Peters
Journal:  Eur J Nucl Med       Date:  1991

Review 3.  Safety profiles of the angiotensin-converting enzyme inhibitors.

Authors:  N J Warner; J E Rush
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 4.  Long-range safety and protective benefits of angiotensin-converting enzyme inhibitors for hypertension. Do we need more clinical trials?

Authors:  M P Sambhi; H Gavras; J I Robertson; W M Smith
Journal:  West J Med       Date:  1993-03

5.  Two routes for 99mTc-DMSA uptake into the renal cortical tubular cell.

Authors:  A M Peters; D H Jones; K Evans; I Gordon
Journal:  Eur J Nucl Med       Date:  1988
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.